Mayo Clinic's new startup to tackle diseases using AI

Central to the new company will be a mix of established medical expertise (from Mayo Clinic's team) and artificial intelligence (using nference's computer experts). The new company will be called Qrativ. The new organization will set-out to discover and develop treatments for diseases which have an unmet medical need. This includes a range of rare diseases affecting specific patient populations. The reason why artificial intelligence and machine learning are needed is due the complexity of biological data, especially data in relation to uncommon diseases and the different drug combinations that the disease needs to be examined against.